MA

Medi Assist Ser.

Q4 FY25Insurance

Medi Assist Ser. Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹361
Market cap₹2.6K Cr
P/E26.4
Updated23 Aug 2026
Read5 min read

The short version

Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%. Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits administrator, focusing on unbundled, technology-driven services (Page 17). - Revenue growth is anticipated from expanding SaaS contracts and new technology offerings like fraud detection, with evolving pricing models (Page 17). - Group premium under management grew 12.4% vs.

From Medi Assist Ser.'s Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%.
  • Focus on evolving from a pure TPA to a health benefits administrator with unbundled SaaS and technology offerings to increase revenue streams.
  • Increasing adoption of add-on/top-up voluntary products in group insurance, improving revenue per life.
  • Growing technology contracts (~1.5%-2% of revenues) with SaaS models expected to scale up as insurers see value in unbundled services.
  • Continued investments in technology for fraud detection and cashless network to create value and enable higher revenue.
  • Market leadership with 30.3% group market share and high retention rates (95%) supporting sustained growth.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Medi Assist Ser. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company continues to invest annually about 5% to 7% of revenues in technology to build core differentiation and innovation (Page 6).
  • Investments focus on enabling unbundling of services, enabling new SaaS offerings and platform businesses that leverage existing capabilities (Page 10-11).
  • These technology investments have proven track records with payout in enhanced monetization, insurance company recognition, and potential for operating leverage (Page 11).
  • Acquisition strategy remains targeted and strategic, such as the recent Paramount TPA acquisition to build a pan-India platform and strengthen insurer relationships (Page 14).

2 more points management made on capital expenditure plans

Top-ranked in Insurance

Ranked on what management guided this quarter

5x potential
1Max Financial
Rev 2Mar 3
2Niva Bupa Health
Rev 2Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
Sign up free to see 2 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Medi Assist Ser. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from Medi Assist Healthcare Services Limited does not explicitly mention the current or expected order book or pending orders. However, the following related points can be noted: - The company has recently received regulatory approval to acquire 100% equity in Paramount Health Services & Insurance TPA Private Limited, indicating strategic expansion. - Medi Assist continues to build partnerships and grow in the third-party administration (TPA) and health benefits administration market, with a focus on unbundling services and technology. - The company reports strong premium under management (over ₹20,000 crore) with growth in both group and retail segments.

2 more points management made on order book & pipeline

Medi Assist Ser. — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹242 Cr, net profit ₹54 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Insurance this season

  • Max Financial (Q4 FY25)

    Individual adjusted first year premium grew 20% in FY '25, surpassing private sector growth of 15% and industry growth of 10%. Key concall takeaways from Max…

  • ICICI Lombard General Insurance Company Ltd (Q4 FY25)

    Focus on profitable growth with a strong emphasis on driving Return on Equity (ROE) between 16% to 20% for sustainable value creation. Key concall takeaways…

  • Niva Bupa Health (Q4 FY25)

    The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Key concall takeaways from Niva Bupa Health Insurance Company…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Medi Assist Ser. Q4 FY25 results?

Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%. Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits administrator, focusing on unbundled, technology-driven services (Page 17). - Revenue growth is anticipated from expanding SaaS contracts and new technology offerings like fraud detection, with evolving pricing models (Page 17). - Group premium under management grew 12.4% vs.

What is Medi Assist Ser. share price analysis?

Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medi Assist Ser. planning capital expenditure?

The company continues to invest annually about 5% to 7% of revenues in technology to build core differentiation and innovation (Page 6).

Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.